Ignite Creation Date:
2025-12-25 @ 1:39 AM
Ignite Modification Date:
2026-06-25 @ 3:11 PM
Study NCT ID:
NCT04725994
Status:
RECRUITING
Last Update Posted:
2024-09-27
First Post:
2021-01-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination with XELOX or Irinotecan in Patients with Advanced Gastric Cancer
Sponsor:
Idience Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ID-VDP-103
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None